Blum KA - Search Results

1

Immunochemotherapy and autologous stem-cell transplantation for untreated patients with mantle-cell lymphoma: CALGB 59909.

Damon LE, Johnson JL, Niedzwiecki D, Cheson BD, Hurd DD, Bartlett NL, Lacasce AS, Blum KA, Byrd JC, Kelly M, Stock W, Linker CA, Canellos GP. Damon LE, et al. Among authors: blum ka. J Clin Oncol. 2009 Dec 20;27(36):6101-8. doi: 10.1200/JCO.2009.22.2554. Epub 2009 Nov 16. J Clin Oncol. 2009. PMID: 19917845 Free PMC article. Clinical Trial.

2

Phase I study of pegylated liposomal doxorubicin and gemcitabine in patients with advanced malignancies.

Fracasso PM, Blum KA, Tan BR, Fears CL, Bartlett NL, Arquette MA, Clark RS. Fracasso PM, et al. Among authors: blum ka. Cancer. 2002 Nov 15;95(10):2223-9. doi: 10.1002/cncr.10937. Cancer. 2002. PMID: 12412177 Free article. Clinical Trial.

3

Antibodies for the treatment of diffuse large cell lymphoma.

Blum KA, Bartlett NL. Blum KA, et al. Semin Oncol. 2003 Aug;30(4):448-56. doi: 10.1016/s0093-7754(03)00251-3. Semin Oncol. 2003. PMID: 12939713 Review.

4

Adult Burkitt leukemia and lymphoma.

Blum KA, Lozanski G, Byrd JC. Blum KA, et al. Blood. 2004 Nov 15;104(10):3009-20. doi: 10.1182/blood-2004-02-0405. Epub 2004 Jul 20. Blood. 2004. PMID: 15265787 Free article. Review.

5

90Yttrium-ibritumomab tiuxetan: a novel treatment for non-Hodgkin's lymphoma.

Blum KA, Bartlett NL. Blum KA, et al. Expert Opin Biol Ther. 2004 Aug;4(8):1323-31. doi: 10.1517/14712598.4.8.1323. Expert Opin Biol Ther. 2004. PMID: 15268665 Review.

6

Effects of pretransplantation treatment with rituximab on outcomes of autologous stem-cell transplantation for non-Hodgkin's lymphoma.

Hoerr AL, Gao F, Hidalgo J, Tiwari D, Blum KA, Mathews V, Adkins DR, Blum W, Devine S, Vij R, Goodnough LT, Dipersio JF, Khoury HJ. Hoerr AL, et al. Among authors: blum ka, blum w. J Clin Oncol. 2004 Nov 15;22(22):4561-6. doi: 10.1200/JCO.2004.05.035. J Clin Oncol. 2004. PMID: 15542807

7

Prolonged follow-up after initial therapy with 2-chlorodeoxyadenosine in patients with indolent non-Hodgkin lymphoma: results of Cancer and Leukemia Group B Study 9153.

Blum KA, Johnson JL, Niedzwiecki D, Piro LD, Saven A, Peterson BA, Byrd JC, Cheson BD; Cancer and Leukemia Group B Study 9153. Blum KA, et al. Cancer. 2006 Dec 15;107(12):2817-25. doi: 10.1002/cncr.22344. Cancer. 2006. PMID: 17120198 Free article. Clinical Trial.

8

Single agent bortezomib in the treatment of relapsed and refractory Hodgkin lymphoma: cancer and leukemia Group B protocol 50206.

Blum KA, Johnson JL, Niedzwiecki D, Canellos GP, Cheson BD, Bartlett NL. Blum KA, et al. Leuk Lymphoma. 2007 Jul;48(7):1313-9. doi: 10.1080/10428190701411458. Leuk Lymphoma. 2007. PMID: 17613759 Clinical Trial.

9

Computed tomography scans do not improve the predictive power of 1996 national cancer institute sponsored working group chronic lymphocytic leukemia response criteria.

Blum KA, Young D, Broering S, Lucas MS, Fischer B, Lin TS, Grever MR, Byrd JC. Blum KA, et al. J Clin Oncol. 2007 Dec 10;25(35):5624-9. doi: 10.1200/JCO.2007.12.1152. Epub 2007 Nov 5. J Clin Oncol. 2007. PMID: 17984187

10

Hodgkin disease/lymphoma.

Hoppe RT, Advani RH, Ambinder RF, Bierman PJ, Bloomfield CD, Blum K, Dabaja B, Djulbegovic B, Forero A, Gordon LI, Hernandez-Ilizaliturri FJ, Hudson MM, Kaminski MS, Love G, Maloney DG, Mansur D, Mauch PM, Moore JO, Schilder RJ, Weiss LM, Winter JN, Yahalom J, Zelenetz AD; National Comprehensive Cancer Network. Hoppe RT, et al. J Natl Compr Canc Netw. 2008 Jul;6(6):594-622. doi: 10.6004/jnccn.2008.0046. J Natl Compr Canc Netw. 2008. PMID: 18597713 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

199 results

Search Page

Filters